| 000 | 01338 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518012353.0 | ||
| 264 | 0 | _c20190412 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1479-7364 | ||
| 024 | 7 |
_a10.1186/s40246-018-0184-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSun, Jiantao | |
| 245 | 0 | 0 |
_aIdentification of drug repurposing candidates based on a miRNA-mediated drug and pathway network for cardiac hypertrophy and acute myocardial infarction. _h[electronic resource] |
| 260 |
_bHuman genomics _c12 2018 |
||
| 300 |
_a52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiomegaly _xgenetics |
| 650 | 0 | 4 | _aComputational Biology |
| 650 | 0 | 4 | _aDrug Repositioning |
| 650 | 0 | 4 | _aGene Regulatory Networks |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMicroRNAs _xgenetics |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMyocardial Infarction _xgenetics |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xgenetics |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xgenetics |
| 700 | 1 | _aYang, Jiemei | |
| 700 | 1 | _aChi, Jing | |
| 700 | 1 | _aDing, Xue | |
| 700 | 1 | _aLv, Nan | |
| 773 | 0 |
_tHuman genomics _gvol. 12 _gno. 1 _gp. 52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s40246-018-0184-0 _zAvailable from publisher's website |
| 999 |
_c29128060 _d29128060 |
||